Zohaib Rana
Dunedin, OTA, New Zealand
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 9 publications
Comprehensive ceRNA Profiling Uncovers Clinically Relevant Hub lncRNAs in Glioblastoma.
Journal: Bioinformatics and biology insights
Published: August 04, 2025
Exploring the Mechanism and Suggesting Combination Therapies for HDAC Inhibitors in Androgen Receptor-Null Prostate Cancer Using Multivariate Statistical Analysis and Data Mining Techniques.
Journal: Bioinformatics and biology insights
Published: July 12, 2022
Anti-Proliferative, Anti-Angiogenic and Safety Profiles of Novel HDAC Inhibitors for the Treatment of Metastatic Castration-Resistant Prostate Cancer.
Journal: Pharmaceuticals (Basel, Switzerland)
Published: August 13, 2021
Key considerations when using the sulforhodamine B assay for screening novel anticancer agents.
Journal: Anti-cancer drugs
Published: July 15, 2021
Cytostatic Action of Novel Histone Deacetylase Inhibitors in Androgen Receptor-Null Prostate Cancer Cells.
Journal: Pharmaceuticals (Basel, Switzerland)
Published: December 22, 2020
Synthesis and Biological Evaluation of (-) and (+)-Spiroleucettadine and Analogues.
Journal: ChemMedChem
Published: December 15, 2020
A Multitargeted Approach: Organorhodium Anticancer Agent Based on Vorinostat as a Potent Histone Deacetylase Inhibitor.
Journal: Angewandte Chemie (International ed. in English)
Published: April 20, 2020
Showing 1-9 of 9
Last Updated: 09/26/2026